Page last updated: 2024-09-04

moxifloxacin and ebselen

moxifloxacin has been researched along with ebselen in 2 studies

Compound Research Comparison

Studies
(moxifloxacin)
Trials
(moxifloxacin)
Recent Studies (post-2010)
(moxifloxacin)
Studies
(ebselen)
Trials
(ebselen)
Recent Studies (post-2010) (ebselen)
3,1575521,6908399366

Protein Interaction Comparison

ProteinTaxonomymoxifloxacin (IC50)ebselen (IC50)
RNA polymerase beta subunit (EC 2.7.7.6), partialEscherichia coli11.6872
Arrestin, beta 1Homo sapiens (human)1.524
MPI proteinHomo sapiens (human)0.19
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonasePlasmodium berghei15.0867
TPA: protein transporter TIM10Saccharomyces cerevisiae S288C5.29
TPA: protein transporter TIM23Saccharomyces cerevisiae S288C0.88
hexokinaseTrypanosoma brucei brucei TREU9270.9009
Spike glycoproteinBetacoronavirus England 10.67
Replicase polyprotein 1abBetacoronavirus England 10.67
neutrophil cytosol factor 1Homo sapiens (human)0.39
phosphomannomutase 2Homo sapiens (human)0.672
perilipin-5Homo sapiens (human)1.101
glucose-6-phosphate 1-dehydrogenase isoform bHomo sapiens (human)13.2
phosphoethanolamine/phosphocholine phosphatase isoform 1Homo sapiens (human)0.111
perilipin-1Homo sapiens (human)3.41
eukaryotic translation initiation factor 4 gamma 1 isoform 4Homo sapiens (human)1.15
eukaryotic translation initiation factor 4E isoform 1Mus musculus (house mouse)1.15
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform aHomo sapiens (human)2.2555
Sulfhydryl oxidase 1Homo sapiens (human)5.4
Transmembrane protease serine 2Homo sapiens (human)0.67
Prostaglandin G/H synthase 1 Bos taurus (cattle)2.1
Gamma-butyrobetaine dioxygenaseHomo sapiens (human)0.742
Bile salt export pumpHomo sapiens (human)10
Procathepsin LHomo sapiens (human)0.67
Replicase polyprotein 1aSevere acute respiratory syndrome-related coronavirus0.67
Replicase polyprotein 1abHuman coronavirus 229E0.67
Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus0.62
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 20.7928
Macrophage migration inhibitory factorHomo sapiens (human)2.4
Insulin-degrading enzymeHomo sapiens (human)0.028
Urease subunit alphaHelicobacter pylori 266953.745
Toxin BClostridioides difficile0.0172
Caspase-1Homo sapiens (human)4.04
Bifunctional epoxide hydrolase 2Homo sapiens (human)0.7575
Methionine aminopeptidase 2Homo sapiens (human)2.43
Spike glycoproteinSevere acute respiratory syndrome-related coronavirus0.67
Urease subunit betaHelicobacter pylori 266953.745
UDP-glucose 4-epimeraseHomo sapiens (human)0.014
Structural capsid protein Human immunodeficiency virus 10.0467
Histone-lysine N-methyltransferase EHMT2Homo sapiens (human)0.4
Angiotensin-converting enzyme 2 Homo sapiens (human)0.67
Histone-lysine N-methyltransferase EHMT1Homo sapiens (human)0.73
Histone deacetylase 6Homo sapiens (human)4.05
Histone deacetylase 9Homo sapiens (human)3.7
Histone deacetylase 5Homo sapiens (human)3.4
large T antigenBetapolyomavirus macacae13.91

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW1

Other Studies

2 other study(ies) available for moxifloxacin and ebselen

ArticleYear
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
    Journal of medicinal chemistry, 2021, 12-09, Volume: 64, Issue:23

    Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors

2021